CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Operating Activities
Net loss	$ (21,470,000)	$ (16,171,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	589,000	603,000
Stock-based compensation	2,214,000	2,240,000
Amortization of right-of-use asset	63,000	0
Noncash lease expense	0	185,000
Noncash interest expense (including related party amounts of $1,036 and $91 for the six months ended June 30, 2024 and 2023, respectively)	1,494,000	91,000
Loss on issuance of financial instruments (including related party amounts of $639 and zero for the six months ended June 30, 2024 and 2023, respectively)	13,886,000	0
Loss on amendments to financial instruments, net	4,939,000	0
Change in fair value of financial instruments	(14,155,000)	2,784,000
Loss on sale of property and equipment, net	9,000	0
Changes in operating assets and liabilities:
Accounts receivable	0	29,000
Prepaid expenses and other current assets	732,000	(296,000)
Accounts payable and accrued expenses	1,560,000	298,000
Other current liabilities	149,000	0
Operating lease liabilities	(43,000)	(190,000)
Other, net	0	(17,000)
Net cash used in operating activities	(10,033,000)	(10,444,000)
Investing activities
Sales of property and equipment	35,000	0
Purchases of capitalized software	(15,000)	(30,000)
Net cash provided by (used in) investing activities	20,000	(30,000)
Financing activities
Proceeds from exercise of common stock options	0	12,000
Proceeds from amendment to the FPA agreements	950,000	0
Proceeds received from sale of FPA Shares	873,000	0
Proceeds from issuance of bridge notes	200,000	0
Proceeds from amendment to the PIPE warrants	250,000	0
Proceeds from related party loans	0	5,000,000
Proceeds from draws on revolving line of credit	0	3,831,000
Payment in connection with letter agreements	(116,000)	0
Payment of transaction costs	(40,000)	(1,742,000)
Payment of debt issuance and modification costs on revolving line of credit	0	(97,000)
Payment of bridge notes	(215,000)	0
Proceeds from repayments of receivables from shareholder	500,000	0
Net cash provided by financing activities	10,066,000	11,829,000
Net increase in cash, cash equivalents, and restricted cash	53,000	1,355,000
Cash, cash equivalents, and restricted cash at the beginning of period	276,000	117,000
Cash, cash equivalents, and restricted cash at the end of period	329,000	1,472,000
Cash and cash equivalents	79,000	1,222,000
Restricted cash	250,000	250,000
Total cash, cash equivalents, and restricted cash	329,000	1,472,000
Supplemental cash flow information
Cash paid for interest expense	222,000	0
Supplemental disclosure of noncash investing and financing activities
Deferred transaction costs included in accounts payable and accrued expenses	0	2,072,000
Conversion of liability classified warrants to equity pursuant to sequencing policy	297,000	0
Right-of-use assets obtained in exchange for new operating lease liability	513,000	0
Exercise of tranche right derivative	572,000	0
Initial issuance of subscription receivable	317,000	0
Capitalized software costs included in accounts payable and accrued expenses	16,000	0
Conversion of liability classified stock to equity	12,000	0
Convertible Bridge Loans
Financing activities
Proceeds from convertible debt	700,000	0
Repayments of convertible debt	(844,000)	0
Convertible Promissory Notes
Financing activities
Proceeds from convertible debt	8,866,000	4,825,000
Payment of financing fees related to convertible promissory notes	(319,000)	0
Repayments of convertible debt	$ (739,000)	$ 0